CanSino's Covax Advances to Phase-3 Trials

CanSino Biologics Inc. has got green light to continue phase-3 trials of its Covid-19 vaccine. CanSino was approved to conduct phase-3 clinical trials in some countries in Europe and Asia.

China's CanSino Biologics Inc. has advanced to phase-3 trials of its coronavirus vaccine with the support of findings of an independent data monitoring committee, said media reports. //

The independent committee "found the drug maker's Covid-19 vaccine met its pre-specified primary safety and efficacy targets under an interim analysis of phase-3 trial data," the report said.

Covid Vaccine in 2021: Pfizer-BioNTech to Produce 2 Billion Doses
US-based pharma major Pfizer and a German pharmaceutical company BioNTech are gonna increase the manufacturing capacity to produce two billion doses of Covid-19 vaccine in this year, 2021.

‘CanSino Biologics Inc. has got green light to continue phase-3 trials of its Covid-19 vaccine. CanSino was approved to conduct phase-3 clinical trials in some countries in Europe and Asia.’

No adverse events related to the vaccine had occurred, according to the Xinhua news agency.

The vaccine candidate, referred to as Ad5-nCoV, is developed by CanSino Biologics Inc. and the Academy of Military Sciences in China.

CanSino was approved to conduct phase-3 clinical trials in some countries in Europe and Asia, Wu Yuanbin, an official with China's Ministry of Science and Technology, said in September last year.

Grocery Stores and Pharmacies to Rollout COVID-19 Vaccines
Pharmacies and Grocery Stores in the U.S. prepare to administer COVID-19 vaccine shots to people.

Source-IANS

Almost 480,000 Kids Infected With COVID-19
Nearly 480,000 children in the US have been infected with the novel coronavirus since the pandemic hit the country earlier.

110-year-old Woman Beats Covid
A 110-year-old woman tested negative for Covid-19 and was discharged from the state-run Medical College near here.